Close Menu

NEW YORK (GenomeWeb) – MDxHealth reported today that its first quarter revenues rose 50 percent, thanks to a 55 percent increase in total test volumes.

For the three months ended March 31, the molecular diagnostics company said revenues rose to $9.7 million from $6.5 million in Q1 2017. Included in the total revenue for Q1 was a license fee payment of $500,000. Product revenues from the firm's ConfirmMDx and SelectMDx tests for prostate cancer amounted to $7.9 million and rose 60 percent from $4.9 million a year earlier.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.